1228020-09-4

Basic information

• Product Name: 4-Methyl-6-(4-methyl-3-phenyl-quinolin-2-ylmethoxy)-[1,3,5]triazin-2-ylamine
• Synonyms: 4-Methyl-6-(4-methyl-3-phenyl-quinolin-2-ylmethoxy)-[1,3,5]triazin-2-ylamine
• CAS NO: 1228020-09-4
• Molecular Weight: 357.415
• Mol File: 1228020-09-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Methyl-6-(4-methyl-3-phenyl-quinolin-2-ylmethoxy)-[1,3,5]triazin-2-ylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-6-(4-methyl-3-phenyl-quinolin-2-ylmethoxy)-[1,3,5]triazin-2-ylamine(1228020-09-4)
• EPA Substance Registry System: 4-Methyl-6-(4-methyl-3-phenyl-quinolin-2-ylmethoxy)-[1,3,5]triazin-2-ylamine(1228020-09-4)

Safety Data

• Hazardous Substances Data: 1228020-09-4(Hazardous Substances Data)

Upstream product

• 1228020-12-9 2-Bromomethyl-4-methyl-3-phenylquinoline 
• 16352-06-0 4-amino-6-methyl-1,3,5-triazine-2-ol 

Relevant articles and documents

QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS

A series of quinoline derivatives, substituted at the 2-position by a heteroaryl group attached via an alkylene chain optionally linked to a heteroatom, and at the 3-position by a carbocyclic or heterocylic ring, being selective inhibitors of PD kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.